Quanterix (QTRX) Cash from Financing Activities (2017 - 2026)
Quanterix (QTRX) reported Cash from Financing Activities of -$770000.0 for Q1 2026, down 927.96% on a YoY basis from $93000.0 in Q1 2025, and down 47.51% quarter-over-quarter from -$522000.0 in Q4 2025.
Quanterix (QTRX) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Quanterix has reported Cash from Financing Activities for 10 years, with the latest figure at -$770000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 927.96% year-over-year to -$770000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.6 million (down 3042.0% YoY), and the FY2025 full-year result was -$708000.0, down 255.26% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$770000.0, down from -$522000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $1.8 million in Q3 2023, with the low at -$770000.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $234117.6 across 5 years, with a median of $150000.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 342.26% — and 2025, when it slumped 1373.17%.
- Quanterix's Cash from Financing Activities stood at $714000.0 in 2022, then sank by 71.85% to $201000.0 in 2023, then plunged by 79.6% to $41000.0 in 2024, then tumbled by 1373.17% to -$522000.0 in 2025, then slumped by 47.51% to -$770000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$770000.0 (Q1 2026), -$522000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | -770,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -770,000.00 |
| Mar 31, 2026 | -770,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Dec 31, 2023 | 201,000.00 |